KCT0002994尚未招募未知
Multicenter, Randomized, Non-inferiority Study on Efficacy and Safety Between Everolimus-eluting Biodegradable Polymer Platinum Chromium and Durable Fluoropolymer Cobalt Chromium Stents in Patients with Diabetes Mellitus: Drug-Eluting Stenting for Patients with Diabetes mellitus II
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 1,268
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1)Age 19 years or older, Diabetic patients
- •2)Coronary artery disease, amenable for percutaneous coronary intervention with Drug Eluting Stent
- •3)Symptom or sign, suggestive of myocardial ischemia (silent myocardial ischemia, chronic stable angina, unstable angina, non-ST elevation myocardial infarction)
- •4)Willing and able to provide informed written consent
排除标准
- •1)ST-elevation myocardial infarction
- •2)Bypass graft lesion, or in-stent restenosis
- •3)left ventricle ejection fraction < 30%
- •4)Cardiogenic shock
- •5)Contraindication to or planned discontinuation of dual antiplatelet therapy within 1 year
- •6)Life expectancy <1 year
- •7)Planned cardiac surgery or planned major non cardiac surgery
- •8)Woman who are breastfeeding, pregnant or planning to become pregnant during the course of the study
- •9)Contraindication or hypersensitivity to contrast agents or heparin
- •10)Contraindication to everolimus
研究者
相似试验
已完成
3 期
A randomized, multicenter non-inferiority trial of 1-day versus 3-day dexamethasone in combination with palonosetron for prevention of nausea and vomiting induced by moderately emetogenic chemotherapycolorectal cancer, lung cancer, breast cancerJPRN-UMIN000009403Hokkaido University Hospital300
进行中（未招募）
1 期
Study to investigate the optimal treatment of a patent ductus arteriosus (Botalli) in preterm newborn infants.Patent ductus arteriosus in the preterm infantEUCTR2017-001376-28-BERadboud University Medical Center564
已完成
不适用
Multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants.Patent ductus arteriosusNL-OMON47250Radboud Universitair Medisch Centrum435
进行中（未招募）
1 期
Study to investigate the optimal treatment of a patent ductus arteriosus (Botalli) in preterm newborn infants.Patent ductus arteriosus in the preterm infantEUCTR2017-001376-28-NLRadboud University Medical Center564
尚未招募
不适用
What is the optimal treatment of a patent ductus arteriosus in preterm infants?preterm, newborn, patent ductus arteriosus, neonatologyte vroeg geborene, open ductus Botalli, neonatologieNL-OMON21314Radboud university medical centerNijmegen, The Netherlands564